{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:35:32Z","timestamp":1762522532738,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Cannabis has been widely used as a medicinal plant for millennia; however, studies related to its main components were first conducted in 1960. Subsequently, laboratories have produced new components and structures related to its active biological properties. Countries that have approved the medicinal use of cannabis impose regulations that govern its clinical and scientific use. One means of administering medicinal cannabis is via a magistral preparation that must have a medical prescription and be prepared in an establishment that meets quality standards to ensure the quantities of its main components, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Furthermore, suppliers must have a clear indication of its use in the patient before prescription. This review shows the published evidence regarding the clinical use of medicinal cannabis magistral preparations in the management of post-chemotherapy nausea and vomiting, neuropathic pain in multiple sclerosis, and anorexia and cachexia in patients with HIV.<\/jats:p>","DOI":"10.3390\/ph14020078","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T02:36:05Z","timestamp":1611196565000},"page":"78","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis"],"prefix":"10.3390","volume":"14","author":[{"given":"Sara","family":"Arias","sequence":"first","affiliation":[{"name":"Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Ch\u00eda 140013, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Leon","sequence":"additional","affiliation":[{"name":"Pain and Palliative Group, Universidad de La Sabana, Ch\u00eda 140013, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3686-5551","authenticated-orcid":false,"given":"Diego","family":"Jaimes","sequence":"additional","affiliation":[{"name":"Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Ch\u00eda 140013, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0243-2299","authenticated-orcid":false,"given":"Rosa-Helena","family":"Bustos","sequence":"additional","affiliation":[{"name":"Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Ch\u00eda 140013, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"ref_1","first-page":"180","article-title":"Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"PT"},{"key":"ref_2","first-page":"133","article-title":"Breve historia sobre la marihuana en Occidente","volume":"67","year":"2018","journal-title":"Rev. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report","volume":"49","author":"Abrams","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_4","unstructured":"National Academies of Sciences, Engineering, and Medicine (2017). The Current State of Evidence and Recommendations for Research. The Health Effects of Cannabis and Cannabinoids, National Academies Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for Medical Use: A Systematic Review and Meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"ref_6","first-page":"49","article-title":"What is medicinal cannabis?","volume":"132","author":"Glass","year":"2019","journal-title":"N. Z. Med. J."},{"key":"ref_7","unstructured":"Nice Guideline Updates Team (2019). National Institute for Health and Care Excellence: Clinical Guidelines, Cannabis-Based Medicinal Products."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical Use of Cannabinoids","volume":"78","year":"2018","journal-title":"Drugs"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s10072-020-04514-2","article-title":"Current application of cannabidiol (CBD) in the management and treatment of neurological disorders","volume":"41","author":"Fiani","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_10","unstructured":"USP 41-NF 36 (2020, December 23). <795> Pharmaceutical Compounding\u2014Nonsterile Preparations US Pharmacopoeia. Available online: https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/compounding\/usp-gc-795-proposed-revision.pdf."},{"key":"ref_11","unstructured":"European Pharmacopoeia (2013). Pharmaceutical Preparations European Pharmacopoeia, European Pharmacopoeia Commission. [7th ed.]."},{"key":"ref_12","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2017). Decreto 613 de 2017."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pca.2722","article-title":"A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS\/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts","volume":"29","author":"Citti","year":"2018","journal-title":"Phytochem. Anal. PCA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jphp.12845","article-title":"Cannabinoids concentration variability in cannabis olive oil galenic preparations","volume":"70","author":"Carcieri","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_15","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos (2017). Procedimiento de Formulaci\u00f3n Magistral. Buenas Pr\u00e1cticas en Farmacia Comunitaria en Espa\u00f1a, Consejo General de Colegios Oficiales de Farmac\u00e9uticos."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ejhpharm-2016-001016","article-title":"Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution","volume":"24","author":"Scheepers","year":"2017","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_17","first-page":"8","article-title":"Formulaci\u00f3n magistral","volume":"18","author":"Granda","year":"2004","journal-title":"Farm. Prof."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fphar.2016.00285","article-title":"Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States","volume":"7","author":"Thomas","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-0114-4","article-title":"An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine","volume":"8","author":"Urits","year":"2019","journal-title":"Pain Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"ref_21","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2006). Resoluci\u00f3n 1478 de 2006."},{"key":"ref_22","unstructured":"Congreso de la Republica de Colombia (2015). Decreto 677 de 2015."},{"key":"ref_23","unstructured":"Congreso de la Republica de Colombia (2017). Ley 1787 de 2016."},{"key":"ref_24","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2017). Resoluci\u00f3n 2892 de 2017."},{"key":"ref_25","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2020). Resoluci\u00f3n 315 de 2020."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cpt.115","article-title":"Medicinal Chemistry of Cannabinoids","volume":"97","author":"Vemuri","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/13543770903436505","article-title":"Latest advances in cannabinoid receptor agonists","volume":"19","author":"Thakur","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fphar.2020.00063","article-title":"Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects","volume":"11","author":"Pauli","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Silvestro, S., Mammana, S., Cavalli, E., Bramanti, P., and Mazzon, E. (2019). Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules, 24.","DOI":"10.3390\/molecules24081459"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lutge, E.E., Gray, A., and Siegfried, N. (2013). The medical use of cannabis for reducing morbidity and mortality in patients with HIV\/AIDS. Cochrane Database Syst. Rev., 30.","DOI":"10.1002\/14651858.CD005175.pub3"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000421-198504000-00006","article-title":"THC or Compazine for the cancer chemotherapy patient\u2014The UCLA study. Part II: Patient drug preference","volume":"8","author":"Ungerleider","year":"1985","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1002\/j.1552-4604.1981.tb02578.x","article-title":"Antiemetic Effect of d-9-Tetrahydrocannabinol in Chemotherapy-Associated nausea and Emesis As Compared to Placebo and Compazin","volume":"21","author":"Orr","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-91-6-825","article-title":"Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer Chemotherapy","volume":"91","author":"Frytak","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/acm.2018.0250","article-title":"Barriers to Achieving Optimal Success with Medical Cannabis: Opportunities for Quality Improvement","volume":"25","author":"Temple","year":"2019","journal-title":"J. Altern. Complement. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Brunetti, P., Pichini, S., Pacifici, R., Busardo, F.P., and Del Rio, A. (2020). Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors. Medicina, 56.","DOI":"10.3390\/medicina56050237"},{"key":"ref_42","unstructured":"Health Canada (2018). Cannabis and the Cannabinoids."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Welch, V., Petticrew, M., Tugwell, P., Moher, D., O\u2019Neill, J., Waters, E., White, H., and PRISMA-Equity Bellagio Group (2012). PRISMA-Equity 2012 extension: Reporting guidelines for systematic reviews with a focus on health equity. PLoS Med., 9.","DOI":"10.1371\/journal.pmed.1001333"},{"key":"ref_44","unstructured":"The Joanna Briggs Institute (2015). Joanna Briggs Institute Reviewers\u2019 Manual: 2015 Edition\/Supplement, The Joanna Briggs Institute."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:13:20Z","timestamp":1760159600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ph14020078"],"URL":"https:\/\/doi.org\/10.3390\/ph14020078","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}